Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition

International Psychogeriatrics

Volumn 27, Issue 1, 2015, Pages 7-17

  Cummings, Jeffrey ^a   Mintzer, Jacobo ^b   Brodaty, Henry ^c   Sano, Mary ^d   Banerjee, Sube ^e   Devanand, D P ^f   Gauthier, Serge ^g   Howard, Robert ^h   Lanctôt, Krista ⁱ   Lyketsos, Constantine G ^j   Peskind, Elaine ^k   Porsteinsson, Anton P ^l   Reich, Edgardo ^m   Sampaio, Cristina ⁿ   Steffens, David ^o   Wortmann, Marc ^p   Zhong, Kate ^a  

^a CLEVELAND CLINIC LOU RUVO CENTER FOR BRAIN HEALTH   (United States)

^b Roper St Francis Hospital   (United States)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF SUSSEX   (United Kingdom)

^f NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^g MCGILL UNIVERSITY   (Canada)

^h KING'S COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^k VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^l Monroe Community Hospital   (United States)

^m UNIVERSIDAD DE BUENOS AIRES   (Argentina)

ⁿ CHDI MANAGEMENT CHDI FOUNDATION   (United States)

^o UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^p Alzheimer's Disease International   (United Kingdom)

more..

Author keywords

aggression; agitation; Alzheimer's disease; clinical trials; cognitive impairment; epidemiology; Food and Drug Administration; International Psychogeriatric Association; intervention

Indexed keywords

AGITATION; ALZHEIMER DISEASE; ARTICLE; CLINICAL RESEARCH; COGNITIVE DEFECT; CONSENSUS DEVELOPMENT; DAILY LIFE ACTIVITY; DRUG DEVELOPMENT; EMOTIONAL STRESS; GERONTOPSYCHIATRY; HEALTH CARE SURVEY; HUMAN; HUMAN RELATION; INSTITUTIONALIZATION; MILD COGNITIVE IMPAIRMENT; MOTOR ACTIVITY; MOTOR DYSFUNCTION; QUALITY OF LIFE; SOCIAL INTERACTION; STUDY; VERBAL HOSTILITY; AGED; BEHAVIOR; CLASSIFICATION; COMPLICATION; DEMENTIA; DISEASE MANAGEMENT; GERIATRIC ASSESSMENT; NOMENCLATURE; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOMOTOR AGITATION;

AGED; BEHAVIORAL SYMPTOMS; COGNITION DISORDERS; DEMENTIA; DISEASE MANAGEMENT; GERIATRIC ASSESSMENT; HUMANS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR AGITATION; TERMINOLOGY AS TOPIC;

EID: 84927697456     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610214001963     Document Type: Article

References (31)

1. American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental DisorDers, 5th edn (DSM-5). Washington, DC: American Psychiatric Association
2. Ballard, C. and Corbett, A. (2010). Management of neuropsychiatric symptoms in people with dementia. CNS Drugs, 24, 729-739. doi:10.2165/11319240
3. Bruen, P. D., McGeown, W. J., Shanks, M. F. and Venneri, A. (2008). Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimers disease. Brain, 131, 2455-2463. doi:10.1093/brain/awn151
4. Bruns, M. B. and Josephs, K. A. (2013). Neuropsychiatry of corticobasal degeneration and progressive supranuclear palsy. International Review of Psychiatry, 25, 197-209. doi:10.3109/09540261.2013.766154
5. Cohen-Mansfield, J., Marx, M. S. and Rosenthal, A. S. (1989). A description of agitation in a nursing home. Journals of Gerontology, 44, M77-M84
6. Cohen-Mansfield, J. and Mintzer, J. E. (2005). Time for change: the role of nonpharmacological interventions in treating behavior problems in nursing home resiDents with dementia. Alzheimer Disease &Associated DisorDers, 19, 37-40
7. Cummings, J. L. and Jeste, D. V. (2007). Pharmacotherapy of neuropsychiatric syndromes in neurologic disorDers: definitional and regulatory aspects. Psychopharmacology Bulletin, 40, 89-98
8. Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A. and Gornbein, J. (1994). The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44, 2308-2314
9. De Deyn, P. P. and Wirshing, W. C. (2001). Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia. Journal of Clinical Psychiatry, 62 (Suppl. 21), 19-22
10. Draper, B. (1999). The International Psychogeriatric Association-Ninth Congress, 15-20 August 1999, Vancouver, Canada. I Drugs, 2, 1133-1135
11. Finkel, S. (2000). Introduction to behavioural and psychological symptoms of dementia (BPSD). International Journal of Geriatric Psychiatry, 15 (Suppl. 1), 2-4
12. Finkel, S. I., Costae Silva, J., Cohen, G., Miller, S. and Sartorius, N. (1996). Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. International Psychogeriatrics, 8 (Suppl. 3), 497-500
13. Geda, Y. E. et al. (2013). Neuropsychiatric symptoms in Alzheimers disease: past progress and anticipation of the future. Alzheimers &Dementia, 9, 602-608
14. Gitlin, L. N., Kales, H. C. and Lyketsos, C. G. (2012). Nonpharmacologic management of behavioral symptoms in dementia. JAMA, 308, 2020-2029. doi:10.1001/jama.2012.36918
15. Gonzalez, D. et al. (2013). Consensus statement on the use of intramuscular aripiprazole for the rapid control of agitation in bipolar mania and schizophrenia. Current Medical Research and Opinion, 29, 241-250. doi:10.1185/03007995.2013.766591
16. Herrmann, N. and Lanctt, K. L. (2007). Pharmacologic management of neuropsychiatric symptoms of Alzheimers disease. Canadian Journal of Psychiatry, 52, 630-646
17. Jeste, D. V. and Finkel, S. I. (2000). Psychosis of Alzheimers disease and related dementias. Diagnostic criteria for a distinct syndrome. American Journal of Geriatric Psychiatry, 8, 29-34
18. Khoo, S. A., Chen, T. Y., Ang, Y. H. and Yap, P. (2013). The impact of neuropsychiatric symptoms on caregiver distress and quality of life in persons with dementia in an Asian tertiary hospital memory clinic. International Psychogeriatrics, 25, 1991-1999. doi:10.1017/S1041610213001518
19. Kong, E. H. (2005). Agitation in dementia: concept clarification. Journal of AdVanced Nursing, 52, 526-536
20. Laughren, T. (2001). A regulatory perspective on psychiatric syndromes in Alzheimers disease. American Journal of Geriatric Psychiatry, 9, 340-345
21. Low, L. F. et al. (2013). The SydneyMultisite Intervention of LaughterBosses and ElDerClowns (SMILE) study: cluster randomised trial of humour therapy in nursing homes. BMJ Open. 3, pii: e002072. doi:10.1136/bmjopen-2012-002072
22. Manoochehri, M. and Huey, E. D. (2012). Diagnosis and management of behavioral issues in frontotemporal dementia. Current Neurology &Neuroscience Reports, 12, 528-536. doi:10.1007/s11910-012-0302-7
23. Okura, T., Plassman, B. L., Steffens, D. C., Llewellyn, D. J., Potter, G. G. and Langa, K. M. (2011). Neuropsychiatric symptoms and the risk of institutionalization and death: the aging, demographics, and memory study. Journal of the American Geriatrics Society, 59, 473-481. doi:10.1111/j.1532-5415.2011.03314.x
24. Olin, J. T. et al. (2003). Provisional diagnostic criteria for depression of Alzheimers disease: description and review. Expert Review Neurotherapeutics, 3, 99-106. doi:10.1586/14737175.3.1.99
25. Reisberg, B., Auer, S. R., Monteiro, I., Boksay, I. and Sclan, S. G. (1997). Behavioral disturbances of dementia: an overview of phenomenology and methodologic concerns. International Psychogeriatrics, 8, 169-180
26. Reisberg, B., Borenstein, J., Salob, S. P., Ferris, S. H., Franssen, E. and Georgotas, A. (1987). Behavioral symptoms in Alzheimers disease: phenomenology and treatment. Journal of Clinical Psychiatry, 48, 9-15
27. SchneiDer, L. S., Dagerman, K. and Insel, P. S. (2006). Efficacy and adverse effects of atypical antipsychotics for dementia: meta-Analysis of randomized, placebo-controlled trials. American Journal of Geriatric Psychiatry, 14, 191-210
28. Senanarong, V. et al. (2004). Agitation in Alzheimers disease is a manifestation of frontal lobe dysfunction. Dementia and Geriatric Cognitive DisorDers, 17, 14-20
29. Swann, A. C. (2013). Activated depression: mixed bipolar disorDer or agitated unipolar depression? Current Psychiatry Reports, 15, 376. doi:10.1007/s11920-013-0376-1
30. Trzepacz, P. T. et al. (2013). Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimers disease. Alzheimers &Dementia, 9, S95-S104. doi:10.1016/j.jalz.2012.10.005
31. World Health Organization, 2014, ICD-10-CM: The Complete Official Draft Code Set (2014 edn). Geneva, Switzerland: OPTUM Insight